Cumberland Pharmaceuticals (CPIX) Current Leases (2019 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Current Leases of $485162.0 for Q1 2026, up 30.74% on a YoY basis from $371094.0 in Q1 2025, and up 3.72% sequentially from $467774.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Current Leases (2019 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 8 years of Current Leases data on file, last reported at $485162.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 30.74% year-over-year to $485162.0; the trailing twelve-month figure through Mar 2026 stood at $485162.0 (up 30.74% YoY), and the FY2025 full-year result was $467774.0, up 31.21% from the prior year.
- Current Leases rose to $485162.0 in Q1 2026, from $467774.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $766488.0 in Q1 2022 to a low of $158369.0 in Q1 2023.
- A 5-year average of $378922.6 and a median of $371094.0 in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases sank 82.17% in 2022 and surged 128.73% in 2024, its largest moves.
- Tracing CPIX's Current Leases over 5 years: stood at $172910.0 in 2022, then surged by 101.31% to $348092.0 in 2023, then grew by 2.42% to $356508.0 in 2024, then jumped by 31.21% to $467774.0 in 2025, then climbed by 3.72% to $485162.0 in 2026.
- Business Quant data shows CPIX's Current Leases at $485162.0 in Q1 2026, $467774.0 in Q4 2025, and $401445.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | 485,162.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 485,162.00 |
| Dec 31, 2025 | 467,774.00 |
| Sep 30, 2025 | 401,445.00 |
| Jun 30, 2025 | 386,077.00 |
| Mar 31, 2025 | 371,094.00 |
| Dec 31, 2024 | 356,508.00 |
| Sep 30, 2024 | 391,688.00 |
| Jun 30, 2024 | 376,780.00 |
| Mar 31, 2024 | 362,244.00 |
| Dec 31, 2023 | 348,092.00 |
| Sep 30, 2023 | 334,288.00 |
| Jun 30, 2023 | 320,837.00 |
| Mar 31, 2023 | 158,369.00 |
| Dec 31, 2022 | 172,910.00 |
| Sep 30, 2022 | 229,605.00 |
| Jun 30, 2022 | 512,324.00 |
| Mar 31, 2022 | 766,488.00 |
| Dec 31, 2021 | 969,677.00 |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 1.07 Mn |